The Current State of Diagnostics for Neuroimmunologic Disorders in Africa
Neurology® Podcast
Dr. Paul Crane talks with Drs. Fiifi Duodu and Malya Sahu about neuroimmunology and multiple sclerosis diagnosis in Africa, including challenges and efforts to improve care. Read the related article . Disclosures can be found at .
info_outline
Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA
Neurology® Podcast
Dr. Elizabeth Coon talks with Dr. Lucy Norcliffe-Kaufmann about the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions. Read the related article in . Disclosures can be found at .
info_outline
August 2026 Recall: Topics in Headache
Neurology® Podcast
The August 2026 recall showcases five incredible interviews highlighting recent advances in headache medicine. The episode begins with Dr. Patricia Pozo-Rosich discussing the latest advancements in headache medicine, focusing on key research findings from 2025. The episode continues with Dr. Jennifer Robblee discussing the latest consensus on refractory migraine. In the third episode of this series, Dr. Michael Eller discusses the implications of CGRP therapies in migraine treatment. The recall concludes with a two-part discussion featuring Drs. Tesha Monteith and Peter Goadsby, who...
info_outline
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
Neurology® Podcast
In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. For more information, please read about the abstract that was presented at the . Read more about the . Disclosures can be found at .
info_outline
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1
Neurology® Podcast
In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. For more information, please read about the abstract that was presented at the . Read more about the . Disclosures can be found at .
info_outline
2026 International Conference on Functional Neurological Disorder
Neurology® Podcast
Dr. Dara Albert talks with Dr. Jon Stone about the latest advancements in FND from the recent International Conference on Functional Neurological Disorder. Dr. Jon Stone shares insights on the field's growth, multidisciplinary care, cultural perspectives, and future directions. Check out the for more information about FND. Disclosures can be found at .
info_outline
Exploring Military Sexual Trauma and Migraine Among US Veterans
Neurology® Podcast
Dr. Stacey Clardy talks with Dr. John Ney about the link between military sexual trauma and migraine among US veterans. Read the related article in . Disclosures can be found at .
info_outline
Preparing ALS Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants
Neurology® Podcast
Dr. Derek Stitt talks with Dr. Jennifer Morganroth about the evolving landscape of genetic testing in ALS, the importance of longitudinal care for at-risk individuals, and the capacity challenges faced by clinics. Read the related article in . Disclosures can be found at .
info_outline
When Drug Marketing Masquerades as Clinical Trials
Neurology® Podcast
Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care. Read the related article on . Disclosures can be found at .
info_outline
Neurology® at 75: The Evolution of the Neurology Journal
Neurology® Podcast
To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal’s history, its evolution, and what lies ahead for the future of Neurology®. Read more about the first . Disclosures can be found at .
info_outlineThe December 2023 replay wraps up the year with four previously posted episodes on neurocritical care. The episode begins with an interview with Dr. Karin Diserens on subtle clinical signs in unresponsive brain-impaired individuals. The episode continues with an interview with Dr. David Greer on updated brain death guidelines. The next interview is with Dr. Monica Lemmon on communicating information about neurologic prognosis. The fourth and final interview is with Drs. Susanne Muehlschlegel and Adeline Goss on the prognostic language used in critical neurologic illness.
Related Podcast Links:
Subtle Clinical Signs in Unresponsive Brain Impairment: https://directory.libsyn.com/episode/index/id/27124839
Updated Pediatric and Adult BD/DNC Consensus Guidelines: https://directory.libsyn.com/episode/index/id/28537073
A Parent-Informed Approach to Communicating Neurologic Prognosis in Infants: https://directory.libsyn.com/episode/index/id/25988781
Language Use in Neurocritical Illness Prognostication: https://directory.libsyn.com/episode/index/id/28137575
Related Article Links:
A Focus on Subtle Signs and Motor Behavior to Unveil Awareness in Unresponsive Brain-Impaired Patients: The Importance of Being Clinical: https://doi.org/10.1212/WNL.0000000000207067
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM: https://doi.org/10.1212/WNL.0000000000207740
The ALIGN Framework: A Parent-Informed Approach to Prognostic Communication for Infants With Neurologic Conditions: https://doi.org/10.1212/WNL.0000000000201600
Prognostic Language in Critical Neurologic Illness: A Multicenter Mixed-Methods Study: https://doi.org/10.1212/WNL.0000000000207462
Disclosures can be found at Neurology.org